Ledger.Open graph →
SEC Form D · filed October 14, 2020

Ankasa Regenerative Therapeutics, Inc

Offering
$12.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LA JOLLA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Tighe J. Reardon · La Jolla, CAExecSanford J. Madigan · La Jolla, CAExec · DirectorSignalfire Opportunities GP, LLC Series 15 · SAN FRANCISCO, CAExecKevin J. Kinsella · La Jolla, CADirectorAndre J. Kobelt, Ph.D · La Jolla, CADirectorWord D. Peake · New York, NYExecSanford J. Madigan · La Jolla, CAExec · DirectorKevin J. Kinsella · La Jolla, CADirectorAndre J. Kobelt, Ph.D · La Jolla, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗